Skip to content

TB rates in UK highest since 1987, but low, stable prevalence of MDR TB

Anti-herpes therapy reduces genital and plasma HIV viral load in MSM not taking HIV therapy

Good medium-term outcomes seen in antiretroviral-treated patients in Cambodia

US and China announce changes to current HIV-positive visitor restrictions

Experts debate how to develop drugs specifically for MDR TB

MDR TB more frequent than thought in southern Africa

Tugela Ferry XDR-TB outbreak continues to grow, but treatment in KZN provides hope

HIV a major risk factor for MDR TB in Ukraine

Governments fail to keep promises on boost for TB research funding, survey finds